Latest research
Latest corporate research
Latest tax enhanced reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax enhanced research
Product reports for investors and advisors
Latest published research
Chesnara Plc
Good 2023 results set platform for future progress
11th Apr 2024
Tissue Regenix
Six consecutive periods of >20% growth
10th Apr 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax enhanced research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
94: How governance enables startup growth and how to start it well | Dermot Campbell of SEEIO
Stay up-to-date with the latest research
Sign up to our newsletter
Register now for 16 April -
Event | Do you know the value of your business? It’s time you do!
Life Sciences research
Collagen Solutions Plc
Life Sciences
Delivering biomaterials for revenue growth
By
Dr Martin Hall
15 Sep 2017
Diurnal Group Plc
Life Sciences
Ready to press the button
By
Dr Martin Hall
14 Sep 2017
Stay up-to-date with the latest research
Sign up to our newsletter
ValiRx
Life Sciences
GeneICE and VAL101 progress
By
Dr Dorothea Hill
13 Sep 2017
Oxford BioMedica
Life Sciences
New era for cell and gene therapies
By
Dr Dorothea Hill
12 Sep 2017
Oxford BioMedica
Life Sciences
Ready for CTL019 approval
By
Dr Dorothea Hill
24 Aug 2017
Tissue Regenix
Life Sciences
CellRight: Transforming US growth prospects
By
Dr Dorothea Hill
10 Aug 2017
Collagen Solutions Plc
Life Sciences
Transitioning to accelerated sustainable growth
By
Dr Martin Hall
25 Jul 2017
Alliance Pharma Plc
Life Sciences
International brands driving growth
By
Dr Martin Hall
24 Jul 2017
Allergy Therapeutics plc
Life Sciences
Strong sales drive market share gains
By
Dr Martin Hall
19 Jul 2017
Oxford BioMedica
Life Sciences
Major deal to supply Novartis CAR-T programmes
By
Dr Dorothea Hill
07 Jul 2017
Evgen Pharma
Life Sciences
Making clinical progress
By
Dr Martin Hall
21 Jun 2017
Prev
1
...
17
18
19
20
21
Next
